This paper examines the potential link between POGZ and Triple Negative Breast Cancer. It posits that POGZ can both encourage tumor growth while also suppressing the early stages of the metastatic cascade. While the foundation wasn’t directly involved in this study, it was authored in part by a member of our medical advisory board, Dr. Alexandre Orthwein.